Tom Vanden Berghe

15PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersInfectious agentsMolecular targetsCardiology (incl. cardiovascular diseases)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 26, 2025
Dual lipid modulation overcomes ferroptosis resistance in high-risk neuroblastoma.

Ine Koeken, Magali Walravens, Roberto Fernández-Acosta

|Oct 24, 2025
Nanopore sequencing enables tissue-of-origin and pathogen detection in plasma cell-free DNA from critically ill patients.

Cyril Willemart, Mojca Strazisar, Tim De Pooter

|Sep 18, 2025
Author Correction: Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.

Samya Van Coillie, Emily Van San, Ines Goetschalckx

|Jul 18, 2025
Potential of biomarker-based enrichment strategies to identify critically ill patients for emerging cell death interventions.

Cyril Willemart, Ruth Seurinck, Tom Stroobants

|Nov 29, 2024
Intravenous iron treatment fuels chronic kidney disease-induced arterial media calcification in rats.

Astrid Van den Branden, Britt Opdebeeck, Saar Adriaensen

|Jul 26, 2024
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease.

Cédric Peleman, Stig Hellemans, Geraldine Veeckmans

Pageof 3

Frequent Collaborators

5 joint publications

Koen Augustyns

4 joint publications

Peter Vandenabeele

2 joint publications

Eric Hoste

2 joint publications

Bartosz Wiernicki